XIENCE Short DAPT XIENCE 28 Global Trial
“The [trial] name actually is coming from the shortest possible DAPT duration in the study which is going to be as short as 28 days after XIENCE implantation, which is quite remarkable.”
— MARCO VALGIMIGLI, MD, PRINCIPAL INVESTIGATOR OF XIENCE 28
Another trial, XIENCE 90, is examining the effects of DAPT discontinuation 90 days after percutaneous coronary intervention (PCI).
Discover more about Xience
AP2944999-WBO Rev. A